跳至主要内容
临床试验/NCT00585741
NCT00585741终止不适用

Pilot Study of 18F-FLT Pet Imaging in Cancer Patients

University of Wisconsin, Madison2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2006年12月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
15
试验地点
2
主要终点
To test whether the cellular response to fractionated radiotherapy leads to observable global change in the uptake of 18F-FLT as assessed by PET imaging

研究概览

简要总结

Fractionated radiotherapy induces an observable change in the proliferative activity as assessed by pre-treatment and early-treatment 18F-FLT PET imaging. This study is designed to investigate 18F-FLT as a PET imaging agent for predicting treatment effectiveness in several tumors and will serve as a pilot study to a planned PO1 submission

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Able to tolerate a PET/CT scan
  • Age of 18 or older
  • signed informed consent
  • being considered for radiotherapy for treatment of CNS mets, Head and neck cancer, lung cancer, prostate cancer or esophageal cancer

排除标准

  • Prior XRT to site being studied
  • severe claustrophobia or inability to tolerate PET/CT
  • unable to provide written consent
  • pregnant or breastfeeding women

结局指标

主要结局

To test whether the cellular response to fractionated radiotherapy leads to observable global change in the uptake of 18F-FLT as assessed by PET imaging

时间窗: end of study

次要结局

  • To assess the technical and logistic feasibility of 18F-FLT scans in a population of cancer patients(end of study)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验